|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/705 | |
| A61K 38/17 | |||
| A61K 38/00 | |||
| C12N 15/00 | |||
| A61K 9/20 |
| (11) | Number of the document | 2332977 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10009258.4 |
| Date of filing the European patent application | 2005-07-25 | |
| (97) | Date of publication of the European application | 2011-06-15 |
| (45) | Date of publication and mention of the grant of the patent | 2015-11-25 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 590765 P | 2004-07-23 | US |
| (72) |
Knopf, John, US
Seehra, Jasbir, US
|
| (73) |
Acceleron Pharma Inc.,
128 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | ActRII receptor polypeptides |
| ActRII receptor polypeptides |